Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $3.08 Million - $3.59 Million
-31,983 Reduced 28.63%
79,737 $8.2 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $10.3 Million - $10.9 Million
96,398 Added 629.15%
111,720 $12.2 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $22.1 Million - $40.4 Million
-354,746 Reduced 95.86%
15,322 $1.74 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $17.8 Million - $25.5 Million
301,367 Added 438.66%
370,068 $22.9 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $2.3 Million - $3.37 Million
-28,994 Reduced 29.68%
68,701 $5.48 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $8.44 Million - $10.7 Million
97,695 New
97,695 $10.3 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $2.32 Million - $2.83 Million
-23,578 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $3.36 Million - $4.04 Million
-36,563 Reduced 60.8%
23,578 $2.58 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $5.19 Million - $5.77 Million
60,141 New
60,141 $5.63 Million
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $12.2 Million - $16.3 Million
-170,355 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $9.9 Million - $12.5 Million
-147,725 Reduced 46.44%
170,355 $12.5 Million
Q3 2020

Nov 16, 2020

SELL
$55.23 - $79.93 $7.55 Million - $10.9 Million
-136,728 Reduced 30.06%
318,080 $24.7 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $6.8 Million - $12.8 Million
225,167 Added 98.05%
454,808 $25.3 Million
Q1 2020

May 15, 2020

BUY
$24.87 - $38.56 $1.01 Million - $1.57 Million
40,652 Added 21.51%
229,641 $6.8 Million
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $3.49 Million - $5.04 Million
137,393 Added 266.29%
188,989 $6.84 Million
Q3 2019

Nov 14, 2019

BUY
$23.0 - $27.97 $1.19 Million - $1.44 Million
51,596 New
51,596 $1.41 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.